Novel Chitosan Derivative as a Systemic Drug Delivery Agent and an Antibiotic Treatment

Tech ID: 24412 / UC Case 2015-035-0

Brief Description

Researchers at the University of California, Irvine have developed a novel chitosan derivative that may be used simultaneously as a systemic drug delivery agent and a systemic antibiotic treatment.

Full Description

Proposed uses of chitosan now under research include drug delivery and currently it is used as a topical antibiotic in bandages. However chitosan is a highly insoluble material. Researchers at UCI have modified chitosan with a few hydrophilic functional groups so that the chitosan derivative is more water soluble. This novel chitosan derivative may be used as a systemic drug delivery agent and/or an oral or intravenous antibiotic.

Novel siRNAs or other nucleic acids may be complexed with this novel derivative chitosan so the complex may be delivered as a drug therapy to a patient. Upon acidic conditions, the nucleic acid is freed from the complex and the derivative chitosan is hydrolyzed thus releasing chitosan which may act as an antibiotic therapy.

Suggested uses

This chitosan derivative may be used to deliver prokaryotic gene silencing CRISPR RNA as a possible treatment for drug resistant infections. Upon acidification, the native chitosan is released. This native chitosan may then damage the bacterial cell membrane and/or interrupt bacterial biological processes by stimulating reactive oxidative species generation. This chitosan/siRNA complex may deliver a one-two punch to combat drug resistant infections.

Patent Status

Country Type Number Dated Case
United States Of America Issued Patent 9,889,204 02/13/2018 2015-035
United States Of America Published Application 20180110866 04/26/2018 2015-035
 

Testing

This chitosan derivative has been tested for its efficiency as a delivery vehicle for pGFP in HeLa cells.

Contact

Learn About UC TechAlerts - Save Searches and receive new technology matches

Other Information

Keywords

Chitosan, Drug delivery, Drug resistance

Categorized As

  • AN INTEGRAL PART OF
  • Institute for Innovation Logo
  • Institute for Innovation Logo

University of California, Irvine Invention Transfer Group
5141 California Avenue, Suite 200, Irvine,CA 92697-7700
Tel: 949.824.2683 | Fax: 949.824.3880
www.ota.uci.edu | ota@uci.edu

© 2014 - 2018, The Regents of the University of California
Terms of use | Privacy Notice